LRRK2 and Parkinson disease: No studies have yet reported cardiovascular impairment in LRRK2 mice, however this is unlikely to be observed given the much-reduced incidence of cardiovascular complications reported in PD patients carrying LRRK2R1441G / G2019S mutations compared with sporadic cases [251].